Mitral regurgitation is an increasing valvular disease that represents a difficult management challenge. Surgical treatment for degenerative mitral regurgitation is the standard of care treatment. Percutaneous therapies have emerged rapidly over the past years as an option for treatment of mitral regurgitation for selected, predominantly high-risk patients. Catheter-based devices mimic these surgical approaches with less procedural risk. Mitraclip® implantation mimics the surgical edge-to-edge leaflet repair technique, reducing the regurgitant area. We review the increasing evidence with the Mitraclip device reported to date.
Eduardo Alegria-Barrero - Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK
Olaf W Franzen - Klinik im Park, Hirslanden Zurich, Zurich, Switzerland
